ENTITY
AFT Pharmaceuticals

AFT Pharmaceuticals (AFT NZ)

51
Analysis
Health CareNew Zealand
AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products. The Company offers medicines for allergy, cough, cold, and flu, eye care, pain management, and laxatives. AFT Pharmaceuticals serves customers worldwide.
more
04 Nov 2024 19:10Issuer-paid

AFT Pharmaceuticals - H125 profitability weighed down by one-offs

AFT Pharmaceuticals has released a trading update ahead of its H125 results, expecting to report a c NZ$2m operating loss for the period ending...

Share
01 Oct 2024 19:10Issuer-paid

AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores

AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for...

Share
10 Aug 2024 07:10Issuer-paid

AFT Pharmaceuticals - Hikma partnership expands to include Combogesic

AFT Pharmaceuticals has expanded its licensing partnership with Hikma in the US to include distribution of the recently launched Combogesic tablets...

Share
06 Aug 2024 06:44Broker

AFT Pharmaceuticals. - Postcard From the UK

Over the past twelve months, AFT Pharmaceuticals (AFT) has launched its Maxigesic tablet into the UK (branded as Combogesic).

Logo
179 Views
Share
10 Jul 2024 19:10Issuer-paid

AFT Pharmaceuticals - Continued execution of footprint expansion

AFT Pharmaceuticals continues to make inroads in expanding its strategic market footprint. Most recently, it announced the entry into China with...

Share
x